"Sinopsis" puede pertenecer a otra edición de este libro.
The modern pharmacopeia has enormous power to alleviate disease, and owes its existence almost entirely to the work of the pharmaceutical industry. This book provides an introduction to the way the industry goes about the discovery and development of new drugs. The first part gives a brief historical account from its origins in the mediaeval apothecaries’ trade, and discusses the changing understanding of what we mean by disease, and what therapy aims to achieve, as well as summarising case histories of the discovery and development of some important drugs. The second part focuses on the science and technology involved in the discovery process: the stages by which a promising new chemical entity is identified, from the starting point of a medical need and an idea for addressing it. A chapter on biopharmaceuticals, whose discovery and development tend to follow routes somewhat different from synthetic compounds, is included here, as well as accounts of patent issues that arise in the discovery phase, and a chapter on research management in this environment. The third section of the book deals with drug development: the work that has to be undertaken to turn the drug candidate that emerges from the discovery process into a product on the market.
The definitive introduction to how a pharmaceutical company goes about its business of discovering and developing drugs.
The second edition has a new editor: Professor Raymond Hill ● non-executive director of Addex Pharmaceuticals, Covagen and of Orexo AB ● Visiting Industrial Professor of Pharmacology in the University of Bristol ● Visiting Professor in the School of Medical and Health Sciences at the University of Surrey ● Visiting Professor in Physiology and Pharmacology at the University of Strathclyde ● President and Chair of the Council of the British Pharmacological Society ● member of the Nuffield Council on Bioethics and the Advisory Council on Misuse of Drugs.
New to this edition:
Features
From customer reviews of the previous edition:
‘... it will have everything you need to know on this module. Deeply referenced and, thus, deeply reliable.
The second edition has a new editor: Professor Raymond Hill ● non-executive director of Addex Pharmaceuticals, Covagen and of Orexo AB ● Visiting Industrial Professor of Pharmacology in the University of Bristol ● Visiting Professor in the School of Medical and Health Sciences at the University of Surrey ● Visiting Professor in Physiology and Pharmacology at the University of Strathclyde ● President and Chair of the Council of the British Pharmacological Society ● member of the Nuffield Council on Bioethics and the Advisory Council on Misuse of Drugs.
New to this edition:
"Sobre este título" puede pertenecer a otra edición de este libro.
Gastos de envío:
EUR 3,76
A Estados Unidos de America
Descripción Paperback. Condición: new. New. Fast Shipping and good customer service. Nº de ref. del artículo: Holz_New_0702042994
Descripción Condición: new. Nº de ref. del artículo: newMercantile_0702042994
Descripción Paperback. Condición: new. Buy for Great customer experience. Nº de ref. del artículo: GoldenDragon0702042994
Descripción Paperback. Condición: new. New Copy. Customer Service Guaranteed. Nº de ref. del artículo: think0702042994
Descripción Condición: new. Nº de ref. del artículo: Hafa_fresh_0702042994
Descripción Condición: New. pp. 368 2nd Edition. Nº de ref. del artículo: 2614947415
Descripción Paperback. Condición: new. New. Nº de ref. del artículo: Wizard0702042994
Descripción Condición: new. Nº de ref. del artículo: FrontCover0702042994
Descripción Paperback. Condición: new. Prompt service guaranteed. Nº de ref. del artículo: Clean0702042994
Descripción Condición: New. pp. 368. Nº de ref. del artículo: 9677704